Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Alphamab Appoints GM and BD EVP | Contract Pharma

What are you searching for?

Sign in
Promotions & Moves

Alphamab Appoints GM and BD EVP

Lin, Liu bring experience in biologics quality management, manufacturing, and business development

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Claudia Lin, Ph.D. has been named general manager of Alphamab (Jiangsu) Biopharmaceuticals Co., Ltd., a newly established subsidiary to manufacture and develop multiple novel biologics in the Alphamab pipeline. Additionally, Mike Liu, Ph.D., was appointed executive vice president to lead global business development.
 
Dr. Lin previously served as vice president at Innovent Biologics, responsible for GMP compliance and Quality management. Prior to Innovent, Dr. Lin served as head of Quality Assurance for Bayer Healthcare Biotech division, responsible for all products in clinical development stages through to initial product launch. She also held various Quality leadership positions in Genentech/Roche.
 
Dr. Liu previously served as head of global business development at Hengrui Pharmaceuticals, where he closed dozens of licensing and partnership agreements with leading multi-national and Chinese companies. Previously, Dr. Liu held positions of increasing responsibility for global commercial development at Alexion Pharmaceuticals and licensing & business development at Purdue Pharma.
 
“We are delighted to have Dr. Lin and Dr. Liu join us,” said Dr. Ting Xu, chairman and chief executive officer of Alphamab. “They are bringing in very valuable expertise and experience in biologics quality management, manufacturing, and business development. As Alphamab grows rapidly, their addition will enable us to expand our global footprint.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters